Medical/Pharmaceuticals
Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA
Clearance Recognises CellDx-Tissue's Dual-Analyte DNA and RNA Workflow Across 517 Cancer-Associated Genes, with ALK, RET and ROS1 Fusion Calls on RNA-Level Evidence NASHIK, India, May 14, 2026 /PRNewswire/ -- Datar Cancer Genetics (DCG), a global precision oncology company, today announced that ...
2026-05-14 23:58
4360
CHEPLAPHARM to Accelerate Global Supply Chain Digitalization with TraceLink MINT
The German pharmaceutical company unifies its digital partner network, laying the foundation for AI-driven supply chain orchestration BOSTON, May 14, 2026 /PRNewswire/ -- TraceLink, the world's largest Agentic Business Network, today announced that the German-based but globally active CHEPLAPHAR...
2026-05-14 22:00
3947
Applications Open for Second Annual Asia-Pacific Global Health Innovation Hackathon on Maternal & Child Nutrition
12 teams, 48 Hours. Innovating for a healthier, more equitable Asia-Pacific SINGAPORE, May 14, 2026 /PRNewswire/ -- Applications are now open for the second annual Asia-Pacific Global Health Innovation Hackathon, to be held in Singapore on 18–19 September 2026. Jointly co-hosted by two SingHealth...
2026-05-14 17:28
6605
Breakthrough skin-tightening device XERF™ arrives in Australia
The new radiofrequency treatment, XERF, is designed to target multiple layers of the skin while prioritizing patient comfort. SYDNEY, May 14, 2026 /PRNewswire/ -- Cynosure Lutronic's XERF is a radiofrequency-based treatment designed to tighten and revitalise skin without the need for needles, nu...
2026-05-14 16:50
4988
Wellcome launches world's largest global prize for mental health science
* The prize, in partnership with Nature, will celebrate breakthroughs in mental health science. It aims to accelerate translation, influence policy and transform lives * This award champions new pharmacological, psychological, social and digital interventions from around the world * The ...
2026-05-14 16:00
3285
SingPost and Fullerton Health to Collaborate on Healthcare Logistics and Last-Mile Medical Delivery
SINGAPORE, May 14, 2026 /PRNewswire/ -- Singapore Post Limited ("SingPost") and Fullerton Healthcare Group Private Limited ("Fullerton Health") have today announced the signing of a Memorandum of Understanding ("MOU") to explore the co-development of a robust, integrated healthcare delivery ecosy...
2026-05-14 15:24
3399
GenesisCare and SeeTreat to bring personalised Offline Adaptive Monitoring to more than 40 radiation oncology centres across Australia
SYDNEY, May 14, 2026 /PRNewswire/ -- Leading Australian cancer care provider, GenesisCare, is pleased to be collaborating with SeeTreat to enable suitable cancer patients access to the latest technology in offline adaptive treatment assessment. SeeTreat's ART.1 software will be rolled out at Gene...
2026-05-14 15:00
3818
Singapore's First Immersive Installation on the Cycles of Intergenerational Harm Opens at One Punggol This May
Why Hurt Children Hurt Children invites Singaporeans to step inside The Black Box — a confrontational, compassionate experience addressing the emotional harm that passes silently from one generation to the next SINGAPORE, May 14, 2026 /PRNewswire/ -- EveryChild.SG, Singapore's movement for child...
2026-05-14 12:11
4192
MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control
- Achieved statistical significance versus standard-of-care (SOC) control across all key efficacy endpoints in the 52-week study - Japan Phase 3 results strengthen CARTISTEM's® global commercial prospects, with Japan biologics license application (BLA) scheduled for 2H 2026 SEOUL, South Korea and...
2026-05-14 10:30
4182
Corti steps up its support for the next wave of healthcare startups as OpenAI pushes into the space and others retreat from Europe
As compliance pressure mounts in every major healthcare AI market, Corti launches its Startup Acceleration Program to help founders clear a €600,000 regulatory barrier and build on the vertical model that outscored OpenAI on its new healthcare benchmark COPENHAGEN, Denmark, May 14, 2026 /PRNewsw...
2026-05-14 00:30
3562
ZEISS expands ophthalmic surgical workflows in Mexico with COFEPRIS approval for ARTEVO 850 and MICOR 700
* Elevates digital visualization for surgeons - ZEISS ARTEVO 850 surgical microscope provides ophthalmic surgeons in Mexico with advanced 3D visualization and end-to-end workflow integration. * Minimizes risk and increases O.R. efficiency for cataract surgery - ZEISS MICOR 700 first hand-held...
2026-05-13 21:00
3430
NYSE Content Update: Global Medical Response to Go Public After $479 Million IPO
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 13, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins...
2026-05-13 20:59
4653
Department of Health - Abu Dhabi and Fred Hutchinson Cancer Center collaborate on cancer research and personalized prevention
ABU DHABI, UAE, May 13, 2026 /PRNewswire/ -- The Department of Health - Abu Dhabi (DoH), regulator of the healthcare sector in the emirate, together with the Abu Dhabi Public Health Center (ADPHC), today announced the execution of a Memorandum of Understanding ("MOU") with Fred Hutchinson Cancer ...
2026-05-13 20:23
3673
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
LONDON, May 13, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in Ai-driven precision medicine, today announced a partnership with Synnovis, one of England's leading pathology providers, to bring liquid biopsy testing to lung and breast cancer patients across the U.K. as par...
2026-05-13 17:00
3125
Getting a leg up on diabetic lower limb amputation with new AI risk prediction model
SINGAPORE, May 13, 2026 /PRNewswire/ -- Personalised risk-based monitoring may soon be the norm for patients with diabetes at high risk of lower extremity amputation (LEA). Jointly developed by Singapore General Hospital (SGH), SingHealth, and the MOH Office for Healthcare Transformation (MOHT), ...
2026-05-13 16:55
2926
New Survey Reveals that Singaporeans Know More about Dementia But Nearly 7 in 10 are Unsure Where to Seek Help
Third national survey by SMU on dementia found that stigma persists; despite rising awareness, preparedness remains below neutral SINGAPORE, May 13, 2026 /PRNewswire/ -- Singaporeans are significantly more aware of dementia than they were five years ago, but most still do not know where to turn ...
2026-05-13 16:11
5660
THE ADECCO GROUP Q1 2026 RESULTS
Strong revenue growth, share gains and improved profitability, supported by rigorous execution ZURICH, Switzerland, May 13, 2026 /PRNewswire/ -- AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange HIGHLIGHTS * Accelerating organic revenue growth of +5.3% TDA yoy * Co...
2026-05-13 12:45
3444
Kelun-Biotech Receives Investigational New Drug Approval from CDE for SKB118, a PD-1 x VEGF Bispecific Antibody
CHENGDU, China, May 12, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that it has received a clinical trial notice from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) appro...
2026-05-13 08:00
4974
GenScript Launches TurboCHO™ Protein Expression Kit, Delivering the Fastest Path to Antibodies in its Class
New kit offers researchers and development teams a meaningful advance in
expression speed and output
BOSTON, May 13, 2026 /PRNewswire/ -- GenScript Biotech Corporation
2026-05-13 00:19
3537
Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine
Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline. LONDON, May 12, 2026 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $2.1 Bi...
2026-05-12 22:27
3967
Week's Top Stories
Most Reposted
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
[Picked up by 309 media titles]
2026-07-30 10:45
J.P. Morgan Private Bank Earns Record 10 Accolades at The Asset Triple A Private Capital Awards 2026
[Picked up by 294 media titles]
2026-07-30 15:00ADA acquires Algonomy, strengthening its intelligent growth platform for a fully agentic experience
[Picked up by 290 media titles]
2026-07-30 15:30
MetaOptics and Elsoft partner to scale next-generation semiconductor optics manufacturing equipment
[Picked up by 286 media titles]
2026-07-30 18:15Most Read
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
2026-07-30 10:45
14133
